Comments: IL HB4055 | 2023-2024 | 103rd General Assembly
Bill Title: Amends the Prior Authorization Reform Act. Provides that notwithstanding any other provision of law, a health insurance issuer or a contracted utilization review organization may not require a prior authorization for drug therapies approved by the U.S. Food and Drug Administration for the treatment of hereditary bleeding disorders any more frequently than 6 months or the length of time the prescription for that dosage remains valid, whichever period is shorter. Effective January 1, 2026.
Spectrum: Moderate Partisan Bill (Republican 9-1)
Status: (Passed) 2024-07-19 - Public Act . . . . . . . . . 103-0659 [HB4055 Detail]
Text: Latest bill text (Chaptered) [HTML]
Spectrum: Moderate Partisan Bill (Republican 9-1)
Status: (Passed) 2024-07-19 - Public Act . . . . . . . . . 103-0659 [HB4055 Detail]
Text: Latest bill text (Chaptered) [HTML]
PolitiCorps Conversations
Start PolitiCorps DebateTitle | PolitiCorps | Access | Comments | Views | Last Post |
---|---|---|---|---|---|
There are no visible public or private PolitiCorps discussions concerning the 2023 Illinois HB4055 at this time. |